Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of activity under the 2016 and 2020 plans

v3.23.1
Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of activity under the 2016 and 2020 plans
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Schedule Of Activity Under The2016 And2020 Plans Abstract  
Shares Underlying Options, Outstanding at Beginning Balance | shares 11,135,432
Weighted Average Exercise Price, Outstanding at Beginning Balance | $ / shares $ 2.85
Weighted Average Remaining Contractual Term (Years), Outstanding at Beginning Balance 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding at Beginning Balance | $ $ 13,031
Shares Underlying Options, Exercisable | shares 8,579,370
Weighted Average Exercise Price, Weighted Average Exercise Price, Exercisable | $ / shares $ 2.8
Weighted Average Remaining Contractual Term (Years), Exercisable 6 years 3 months 18 days
Aggregate Intrinsic Value, Exercisable | $ $ 26,188
Shares Underlying Options, Granted | shares 832,500
Weighted Average Exercise Price, Granted | $ / shares $ 0.4
Aggregate Intrinsic Value, Weighted Average Remaining Contractual Term (Years), Granted
Shares Underlying Options, Canceled | shares (977,638)
Weighted Average Exercise Price, Canceled | $ / shares $ 3.2
Weighted Average Remaining Contractual Term (Years), Canceled
Shares Underlying Options, Forfeited | shares (1,476,670)
Weighted Average Exercise Price, Forfeited | $ / shares $ 2.6
Shares Underlying Options, Outstanding at Ending Balance | shares 9,513,624
Weighted Average Exercise Price, Outstanding at Ending Balance | $ / shares $ 2.64
Weighted Average Remaining Contractual Term (Years), Outstanding at Ending Balance 6 years 6 months
Aggregate Intrinsic Value, Outstanding at Ending Balance | $ $ 26,188